 Estrogen Replacement Therapy
"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
| Descriptor ID |
D015914
|
| MeSH Number(s) |
E02.319.452.150
|
| Concept/Terms |
Estrogen Replacement Therapy- Estrogen Replacement Therapy
- Estrogen Replacement Therapies
- Replacement Therapies, Estrogen
- Therapies, Estrogen Replacement
- Therapy, Estrogen Replacement
- Replacement Therapy, Estrogen
Estrogen Replacement- Estrogen Replacement
- Estrogen Replacements
- Replacements, Estrogen
- Replacement, Estrogen
|
Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".
Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".
This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 | | 1996 | 3 | 0 | 3 | | 1997 | 4 | 1 | 5 | | 1998 | 5 | 1 | 6 | | 1999 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 4 | 0 | 4 | | 2002 | 4 | 1 | 5 | | 2003 | 9 | 1 | 10 | | 2004 | 2 | 2 | 4 | | 2005 | 2 | 1 | 3 | | 2006 | 1 | 4 | 5 | | 2007 | 1 | 0 | 1 | | 2008 | 6 | 1 | 7 | | 2009 | 1 | 3 | 4 | | 2010 | 2 | 2 | 4 | | 2011 | 3 | 1 | 4 | | 2012 | 1 | 2 | 3 | | 2013 | 1 | 3 | 4 | | 2014 | 3 | 2 | 5 | | 2015 | 6 | 2 | 8 | | 2016 | 2 | 0 | 2 | | 2017 | 1 | 1 | 2 | | 2018 | 0 | 1 | 1 | | 2019 | 3 | 1 | 4 | | 2020 | 4 | 1 | 5 | | 2021 | 2 | 0 | 2 | | 2022 | 0 | 1 | 1 | | 2023 | 2 | 0 | 2 | | 2024 | 0 | 2 | 2 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.
-
Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
-
Harrington LB, Powers JD, Bayliss EA, Fortmann SP, Shortreed SM, Walker RL, Floyd JS, Kuntz J, Fuller S, Alberston-Junkans L, Lee MH, Temposky LA, Dublin S. Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study. Am J Epidemiol. 2024 Oct 07; 193(10):1417-1425.
-
Santoro N. Basics of the menopause transition. Menopause. 2024 Oct 01; 31(10):921-922.
-
Kantarci K, Tosakulwong N, Lesnick TG, Kara F, Kendall-Thomas J, Kapoor E, Fields JA, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause. 2024 Jan 01; 31(1):10-17.
-
Petrick JL, Joslin CE, Johnson CE, Camacho TF, Peres LC, Bandera EV, Barnard ME, Beeghly A, Bethea TN, Dempsey LF, Guertin K, Harris HR, Moorman PG, Myers ER, Ochs-Balcom HM, Rosenow W, Setiawan VW, Wu AH, Schildkraut JM, Rosenberg L. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium. Br J Cancer. 2023 12; 129(12):1956-1967.
-
Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, Clendenen T, Du M, Johnson L, Liao LM, Michels KA, O'Connell K, Olson SH, Petruzella S, Rebbeck TR, Setiawan VW, Trabert B, Weiss NS, Wentzensen N, Wilkens L, Wise LA. Risk factors for endometrial cancer in Black women. Cancer Causes Control. 2023 May; 34(5):421-430.
-
Santoro N, Liss J. Compounded Bioidentical Hormones: Myths and Realities. Clin Obstet Gynecol. 2021 12 01; 64(4):793-802.
-
Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021 01 01; 106(1):1-15.
-
Pinkerton JV, Faubion SS, Kaunitz AM, Liu JH, Manson JE, Santoro NF, Shifren JL, Stuenkel CA. The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy. Menopause. 2020 11; 27(11):1199-1201.
-
Pinkerton JV, Liu JH, Santoro NF, Thurston RC, Joffe H, Faubion SS, Manson JE. Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. Menopause. 2020 06; 27(6):611-613.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|